Terms: = Lymphoma AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
118 results:
1. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
2. [
Xu HQ; Song LJ; Ding CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047
[TBL] [Abstract] [Full Text] [Related]
3. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
4. Expression of "DNA damage response" pathway genes in diffuse large B-cell lymphoma: The potential for exploiting synthetic lethality.
Mansoor A; Kamran H; Rizwan H; Akhter A; Roshan TM; Shabani-Rad MT; Bavi P; Stewart D
Hematol Oncol; 2024 Jan; 42(1):e3225. PubMed ID: 37795760
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma.
Gong C; Wu J; Song W; Li H; Shi C; Gao Y; Shi Z; Li Z; Zhang M
Ann Hematol; 2023 Oct; 102(10):2845-2855. PubMed ID: 37500898
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant treatment among Lymphoid Malignancies.
Ruiz M; Rubens M; Ramamoorthy V; Chavez CB; Saxena A
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e307-e313. PubMed ID: 37244799
[TBL] [Abstract] [Full Text] [Related]
7. Subcutaneous Microabscesses and Myositis as Part of Immune Reconstitution Inflammatory Syndrome due to Chronic Disseminated Candidiasis in a Child With Acute Lymphoblastic Leukemia.
Reddy NA; Addala S; S S S; Lashkari HP
J Pediatr Hematol Oncol; 2023 May; 45(4):e555-e559. PubMed ID: 37083275
[TBL] [Abstract] [Full Text] [Related]
8. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
9. Low Expression of brca1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic Leukemia.
Villegas-Ruíz V; Medina-Vera I; Arellano-Perdomo P; Castillo-Villanueva A; Galván-Diaz CA; Paredes-Aguilera R; Rivera-Luna R; Juárez-Méndez S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e167-e173. PubMed ID: 36730467
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma].
Yu Y; Xiong WJ; Chen JW; Jiao Y; Yan YT; Wang Q; Zou DH; Liu W; Liu HM; Lyu R; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):568-574. PubMed ID: 36709134
[No Abstract] [Full Text] [Related]
11. Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.
Barszczewska-Pietraszek G; Drzewiecka M; Czarny P; Skorski T; Śliwiński T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613762
[TBL] [Abstract] [Full Text] [Related]
12. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells.
Hiroki H; Akahane K; Inukai T; Morio T; Takagi M
Int J Hematol; 2023 May; 117(5):748-758. PubMed ID: 36575328
[TBL] [Abstract] [Full Text] [Related]
14. Human Immunodeficiency Virus: Opportunistic Infections and Beyond.
Siripurapu R; Ota Y
Neuroimaging Clin N Am; 2023 Feb; 33(1):147-165. PubMed ID: 36404041
[TBL] [Abstract] [Full Text] [Related]
15. [OCULAR SARCOIDOSIS].
Qassoom A; Raviv Sasportas E; Bar A
Harefuah; 2022 Oct; 161(10):628-632. PubMed ID: 36315210
[TBL] [Abstract] [Full Text] [Related]
16. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.
Usui Y; Iwasaki Y; Matsuo K; Endo M; Kamatani Y; Hirata M; Sugano K; Yoshida T; Matsuda K; Murakami Y; Maeda Y; Nakagawa H; Momozawa Y
Cancer Sci; 2022 Nov; 113(11):3972-3979. PubMed ID: 36065483
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical procedures for intraocular lymphomas].
Schiemenz C; Lüken S; Klassen AM; Ranjbar M; Illerhaus G; Fend F; Heindl LM; Chronopoulos A; Grisanti S; Kakkassery V
Ophthalmologie; 2022 Jul; 119(7):675-685. PubMed ID: 35925411
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract] [Full Text] [Related]
19. [Functional investigation of chimeric antigen receptor T cells targeting LMP1 antigen].
He HZ; Xing YY; Zhang Y; Xu YX; Tian Z; Xing HY; Tang KJ; Rao Q; Wang JX; Wang M
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):229-234. PubMed ID: 35405781
[No Abstract] [Full Text] [Related]
20. Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
Denier M; Tick S; Dubois R; Dulery R; Eller AW; Suarez F; Burroni B; Maurage CA; Bories C; Konopacki J; Puech M; Bouscary D; Cantalloube A; Héron E; Marçais A; Habas C; Theillac V; Keilani C; Bonhomme GR; Gallagher DS; Boumendil J; Abarah W; Sedira N; Bertin S; Choquet S; Sahel JA; Merabet L; Brignole-Baudouin F; Putterman M; Errera MH
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334633
[No Abstract] [Full Text] [Related]
[Next]
